"Hello, everyone. I am currently working on the topic of PM2.5 and its association with lung injuries. Could anybody please provide guidance on exploring new molecular pathways and potential entry points for my research?"
The question you present is interesting and necessary. For more than 20 years, various authors, among whom Oberdörster and Donaldson stand out, have done numerous works on the biokinetics and possible toxicity of NPs.
Briefly, I attach some aspects that may be useful to you.
NP. ENTRY ROUTES TO THE HUMAN ORGANISM
1. Through the digestive system (ingestion)
2. Through the respiratory tract (inhalation, instillation)
3. Through the skin (direct exposure)
4. Injection
TOXICITY INHALED PARTICLES. FACTORS
Dependent on the type of particle
Chemical composition
Shape and size
Exhibition
Intensity
Duration
Individual
Purification capacity (defense mechanisms)
Airway geometry
Predisposition (Genetics)
In nanoparticles, in addition: Ubiquity, Translocation, Surface area
CONSENSUS OF F-Q PARAMETERS AND CHARACTERISTICS TO ASSESS TOXIC MECHANISMS OF NPs
Method of synthesis thereof
Composition
Size
Shape
Distribution
State of agglomeration or aggregation
Purity
Dissolution
Surface area (NPs have a large surface area per unit mass).
NP TOXICITY. POSSIBLE MECHANISMS
-Card, J.W. et al. Am J Physiol Lung Cell Mol Physiol 295: L400-L411 2008
-Li et al: Exp Biol Med. 2010. 235:1025-33.)
Pulmonary disease due to exposure to nanoparticles. B. Calvo Cerrada; A. López-Guillén, P Sanz; G Martí. DOI: 10.1201/9781351008884-26